Education
About Us
Working with TipRanks
Follow Us
Jones Erin Insider Profile
4 Followers
Jones Erin, EVP, Global Regulatory Affairs and Quality at Gritstone Oncology, holds 20.00K shares in Gritstone Oncology (Ticker: GRTS). Most recently, Jones Erin Bought $10,000 shares of Gritstone Oncology on Aug 19, 2020 for an estimated value of 3.40K.
Jones Erin Gritstone Oncology (GRTS)EVP, Global Regulatory Affairs and Quality
Gritstone Oncology (GRTS)
EVP, Global Regulatory Affairs and Quality
Ranked #51,908 out of 78,624 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-18.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP, Global Regulatory Affairs and Quality
Roles that Jones Erin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jones Erin
Jones Erin's Trading History
List of latest transactions for each holding click on a transaction to see Jones Erin's performance on stock
You May Also Like
Jones Erin insider profile FAQ
What is the percentage of profitable transactions made by Jones Erin?
The percentage of profitable transactions made by Jones Erin is 0%.
What is the average return per transaction made by Jones Erin?
The average return per transaction made by Jones Erin is -18.40%.
What stocks does Jones Erin hold?
Jones Erin holds: GRTS stocks.
What was Jones Erin’s latest transaction?
Jones Erin latest transaction was an Informative Buy of $3.40K.
What was Jones Erin's most profitable transaction?
Jones Erin’s most profitable transaction was an Informative Buy of GRTS stock on August 19, 2020. The return on the trade was -4.60%.
What is Jones Erin's role in Gritstone Oncology?
Jones Erin's role in Gritstone Oncology is EVP, Global Regulatory Affairs and Quality.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.